The advantage of combining systemic therapies like chemotherapy and PARP1-i with local therapies like ionizing radiation and hyperthermia is that the latter two will not enhance the systemic side effects of the former two, while at the same time the local tumor effects are enhanced as a result, which has been shown in the present study. The gene discussed is PARP1; the disease is neoplasm.